OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
301156$20.4756

Shanghai Menon Animal Nutrition Technology Co Ltd

Fishing & FarmingVerified

The company's capital structure is characterized by a low debt-to-equity ratio of 0.0, indicating a conservative leverage profile. Its liquidity position is assessed as medium, with a current ratio of 4.28, suggesting strong short-term liquidity. However, the company has negative net cash after subtracting total debt, which raises some liquidity concerns. Profitability metrics show a return on equity (ROE) of 7.51% and a return on assets (ROA) of 6.61%, both below the typical thresholds for high-performing firms in the food and agriculture sector. The gross margin is 30.13% (169,119,020 / 561,265,720), and the operating margin is 10.77% (60,433,830 / 561,265,720), which are in line with industry norms but not exceptional. The company's revenue is concentrated in feed additives and enzymatic protein feed ingredients, with a disclosed focus on domestic and overseas markets. No specific segment or geographic revenue breakdown is provided, but the company's primary operations are in China. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory is mixed. While it reported a revenue of 561.27 million CNY in the latest period, the free cash flow is negative at -81.10 million CNY, and capital expenditures are -117.85 million CNY, indicating significant reinvestment in operations. The outlook for the current fiscal year is not explicitly provided, but the negative free cash flow suggests potential pressure on growth without external financing. Risk factors include a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued additional shares recently. The company's valuation is elevated, with a price-to-earnings ratio of 52.58 and a price-to-book ratio of 3.95, which may reflect investor optimism or overvaluation relative to fundamentals. Recent events include the company's continued focus on feed additive production and expansion in both domestic and overseas markets. No specific recent filings or transcripts are provided, but the company's ongoing operations suggest a stable, albeit capital-intensive, business model.

30-day price · 301156+1.97 (+10.6%)
Low$17.50High$21.40Close$20.50As of15 May, 00:00 UTC
Profile
CompanyShanghai Menon Animal Nutrition Technology Co Ltd
Ticker301156.SZ
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFishing & Farming
AI analysis

Business. Shanghai Menon Animal Nutrition Technology Co Ltd develops, produces, and sells feed additives and enzymatic protein feed ingredients for use in pigs, ruminants, poultry, and aquaculture, with operations in domestic and overseas markets.

Classification. The company is classified under the Consumer Non-Cyclicals economic sector, Food & Beverages business sector, and Fishing & Farming industry with a confidence level of 0.92.

The company's capital structure is characterized by a low debt-to-equity ratio of 0.0, indicating a conservative leverage profile. Its liquidity position is assessed as medium, with a current ratio of 4.28, suggesting strong short-term liquidity. However, the company has negative net cash after subtracting total debt, which raises some liquidity concerns. Profitability metrics show a return on equity (ROE) of 7.51% and a return on assets (ROA) of 6.61%, both below the typical thresholds for high-performing firms in the food and agriculture sector. The gross margin is 30.13% (169,119,020 / 561,265,720), and the operating margin is 10.77% (60,433,830 / 561,265,720), which are in line with industry norms but not exceptional. The company's revenue is concentrated in feed additives and enzymatic protein feed ingredients, with a disclosed focus on domestic and overseas markets. No specific segment or geographic revenue breakdown is provided, but the company's primary operations are in China. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory is mixed. While it reported a revenue of 561.27 million CNY in the latest period, the free cash flow is negative at -81.10 million CNY, and capital expenditures are -117.85 million CNY, indicating significant reinvestment in operations. The outlook for the current fiscal year is not explicitly provided, but the negative free cash flow suggests potential pressure on growth without external financing. Risk factors include a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued additional shares recently. The company's valuation is elevated, with a price-to-earnings ratio of 52.58 and a price-to-book ratio of 3.95, which may reflect investor optimism or overvaluation relative to fundamentals. Recent events include the company's continued focus on feed additive production and expansion in both domestic and overseas markets. No specific recent filings or transcripts are provided, but the company's ongoing operations suggest a stable, albeit capital-intensive, business model.
Key takeaways
  • The company maintains a conservative capital structure with no long-term debt and a low debt-to-equity ratio.
  • Profitability metrics are in line with industry norms but not exceptional, with ROE and ROA at 7.51% and 6.61%, respectively.
  • Revenue is concentrated in feed additives and enzymatic protein feed ingredients, with a focus on domestic and overseas markets.
  • Free cash flow is negative, indicating significant reinvestment in operations and potential pressure on growth.
  • The company's valuation is elevated, with a high price-to-earnings ratio of 52.58 and a price-to-book ratio of 3.95.
  • Liquidity risk is medium due to the negative net cash position, but dilution risk is low.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$561.3M
Gross profit$169.1M
Operating income$60.4M
Net income$54.8M
R&D
SG&A
D&A
SBC
Operating cash flow$66.5M
CapEx-$117.9M
Free cash flow-$81.1M
Total assets$829.0M
Total liabilities$98.8M
Total equity$730.2M
Cash & equivalents
Long-term debt$346.1k
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$20.47
Market cap$2.88B
Enterprise value$2.88B
P/E52.6
Reported non-GAAP P/E
EV/Revenue5.1
EV/Op income47.7
EV/OCF43.4
P/B4.0
P/Tangible book4.0
Tangible book$730.2M
Net cash-$346.1k
Current ratio4.3
Debt/Equity0.0
ROA6.6%
ROE7.5%
Cash conversion1.2%
CapEx/Revenue-21.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food · cohort 445 companies
Metric301156Activity
Op margin10.8%3.2% medp25 3.2% · p75 3.2%top quartile
Net margin9.8%2.1% medp25 2.1% · p75 2.1%top quartile
Gross margin30.1%9.2% medp25 9.2% · p75 9.2%top quartile
CapEx / revenue-21.0%-3.9% medp25 -9.9% · p75 -1.1%bottom quartile
Debt / equity0.0%8.7% medp25 8.7% · p75 8.7%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 18:32 UTC#a27a67ed
Market quoteclose CNY 20.47 · shares 0.14B diluted
no public URL
2026-05-04 10:34 UTC#0e184346
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 10:35 UTCJob: 81b96074